(lp0
S'Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock and ... GlobeNewswire  - Mar 13, 2017 HAYWARD, Calif., March 13, 2017  -- Anthera Pharmaceuticals, Inc.   today announced that it intends to offer and sell shares of its common stock and warrants to purchase shares of its common stock in an&nbsp;...'
p1
aS"Guess, Anthera Pharmaceuticals Dive into Thursday's 52-Week Low Club 24/7 Wall St. - Mar 16, 2017 Anthera Pharmaceuticals Inc.  dropped about 11% Thursday, to post a new 52-week low of $0.40 after closing at $0.45 on Wednesday."
p2
aS'Anthera Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 16 Equities.com - Mar 16, 2017 Anthera Pharmaceuticals Inc.  traded on unusually high volume on Mar. 16, as the stock gained 1.43% to close at $0.41.ANTHERA PHARMACEUTICALS,INC.  Files An 8-K Entry into a Material ... - Market ExclusiveThe Anthera Pharmaceuticals Inc  Stake Maintained by Sabby Management, LLC - Petro Global News 24'
p3
aS'ANTHERA PHARMACEUTICALS, INC.  Files An 8-K Results of Operations ... Market Exclusive - Feb 27, 2017 Anthera Pharmaceuticals, Inc.  is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including enzyme replacement therapies and autoimmune diseases.Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead ... - PR Newswire '
p4
aS'Anthera Pharmaceuticals Inc.  Moves Lower on Volume Spike for March 15 Equities.com - Mar 15, 2017 Anthera Pharmaceuticals Inc.  traded on unusually high volume on Mar. 15, as the stock lost 2.46% to close at $0.40. On the day, Anthera Pharmaceuticals Inc. saw 4.18 million shares trade hands on 6,735 trades. Considering that the stock averages&nbsp;...Anthera Pharmaceuticals Announces Pricing of $15.0 Million Public Offering of ... - GlobeNewswire '
p5
aS'Anthera Pharmaceuticals Inc : Ignore The Lawsuits Insider Financial - Feb 23, 2017 Levi &amp; Korsinsky, Lifshitz &amp; Miller, Bronstein, Gewirtz &amp; Grossman, Johnson &amp; Weaver - just some of the LLPs flooding the PR streams for Anthera Pharmaceuticals Inc  at the major financial news outlets. Every one of these companies claims&nbsp;...Anthera Pharmaceuticals Inc.  Moves Lower on Volume Spike for February 23 - Equities.com'
p6
aS'Anthera Pharmaceuticals, Inc.  And Its Technicals Provide Timely Picture NY Stock News - 22 hours ago The technicals for Anthera Pharmaceuticals, Inc.  has spoken via its technical chart and the message is loud and clear.'
p7
aS'IMPORTANT ANTHERA PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler ... GlobeNewswire  - Feb 24, 2017 INVESTOR ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of purchasers of Anthera Pharmaceuticals, Inc.'
p8
aS'Anthera Pharmaceuticals Inc.  Plunges 8.39% on March 03 Equities.com - Mar 3, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Friday March 03 as shares tumbled 8.39%, or a loss of $-0.0586 per share, to close at $0.64.Featured Stock to Focus: Synergy Pharmaceuticals, Inc.  - HugoPress'
p9
aS'Anthera Pharmaceuticals Inc.  Plunges 5.29% on March 02 Equities.com - Mar 2, 2017 Anthera Pharmaceuticals Inc.  had a rough trading day for Thursday March 02 as shares tumbled 5.29%, or a loss of $-0.039 per share, to close at $0.70.Anthera Pharmaceuticals, Inc.  Insider Ownership stands at 0.1 - The Newburgh PressCan the next move of Anthera Pharmaceuticals, Inc.  be predicted? - The Oracle Examiner'
p10
a.